Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

Receptor Agonists

Faculty Opinions recommendation of SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734434782.793555944 ◽

2019 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Secondary Prevention ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Cardiovascular Outcome ◽

Primary And Secondary Prevention ◽

Renal Outcomes

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(21)00203-5 ◽

2021 ◽

Author(s):

Naveed Sattar ◽

Matthew M Y Lee ◽

Søren L Kristensen ◽

Kelley R H Branch ◽

Stefano Del Prato ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Cardiovascular Mortality ◽

Meta Analysis ◽

Randomised Trials ◽

Receptor Agonists

Generalizability of sodium-glucose co-transporter-2 inhibitors cardiovascular outcome trials to the type 2 diabetes population: a systematic review and meta-analysis

Cardiovascular Diabetology ◽

10.1186/s12933-020-01067-8 ◽

2020 ◽

Vol 19 (1) ◽

Cited By ~ 5

Author(s):

Marco Castellana ◽

Filippo Procino ◽

Rodolfo Sardone ◽

Pierpaolo Trimboli ◽

Gianluigi Giannelli

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in Asians with type 2 diabetes: A systematic review and meta-analysis of cardiovascular outcome trials

Diabetes & Metabolic Syndrome Clinical Research & Reviews ◽

10.1016/j.dsx.2020.04.051 ◽

2020 ◽

Vol 14 (4) ◽

pp. 715-722

Author(s):

Awadhesh Kumar Singh ◽

Ritu Singh

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Receptor Agonist ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Cardiovascular Outcome ◽

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

The Lancet ◽

10.1016/s0140-6736(18)32590-x ◽

2019 ◽

Vol 393 (10166) ◽

pp. 31-39 ◽

Cited By ~ 749

Author(s):

Thomas A Zelniker ◽

Stephen D Wiviott ◽

Itamar Raz ◽

Kyungah Im ◽

Erica L Goodrich ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Secondary Prevention ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Cardiovascular Outcome ◽

Primary And Secondary Prevention ◽

Renal Outcomes

Comparative safety of glucagon like peptide‑1 receptor agonists in patients with type 2 diabetes: a network meta-analysis of cardiovascular outcome trials

10.37766/inplasy2020.8.0122 ◽

2020 ◽

Author(s):

Chuanjun Zhuo ◽

Hongjun Tian ◽

Lina Wang ◽

Xiangyang Gao ◽

Li Ding ◽

...

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Comparative Safety

Type 2 diabetes and risk of heart failure: a systematic review and meta-analysis from cardiovascular outcome trials

Endocrine ◽

10.1007/s12020-019-01931-y ◽

2019 ◽

Vol 65 (1) ◽

pp. 15-24 ◽

Cited By ~ 6

Author(s):

Dario Giugliano ◽

Maria Ida Maiorino ◽

Miriam Longo ◽

Giuseppe Bellastella ◽

Paolo Chiodini ◽

...

Keyword(s):

Heart Failure ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(20)30038-3 ◽

2020 ◽

Vol 8 (5) ◽

pp. 418-435 ◽

Cited By ~ 19

Author(s):

Olivia R Ghosh-Swaby ◽

Shaun G Goodman ◽

Lawrence A Leiter ◽

Alice Cheng ◽

Kim A Connelly ◽

...

Keyword(s):

Heart Failure ◽

Systematic Review ◽

Type 2 Diabetes ◽

At Risk ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Glucose Lowering ◽

Effect of background insulin therapy on cardiovascular outcomes with SGLT-2 inhibitors in type 2 diabetes: A Meta-analysis of Cardiovascular Outcome Trials

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2021.108648 ◽

2021 ◽

pp. 108648

Author(s):

Awadhesh Kumar Singh ◽

Ritu Singh

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Cardiovascular Outcome ◽

Glucagon-Like Peptide-1 Receptor Agonists in Adult Patients With Type 2 Diabetes: Review of Cardiovascular Outcome Trials

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2019.08.011 ◽

2020 ◽

Vol 44 (1) ◽

pp. 68-77 ◽

Cited By ~ 4

Author(s):

Elodie M. Varin ◽

Brent A. McLean ◽

Julie A. Lovshin

Keyword(s):

Type 2 Diabetes ◽

Adult Patients ◽

Cardiovascular Outcome ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1